Virtual Medicinal Product (VMP) - Olanzapine embonate 210mg powder and solvent for suspension for injection vials

Name Details

Name Start Date End Date
Name Current Name Olanzapine embonate 210mg powder and solvent for suspension for injection vials Start Date 26-07-2010 End Date
Previous Name Previous Name Olanzapine pamoate 210mg powder and solvent for suspension for injection vials Start Date 14-04-2010 End Date 25-07-2010
Abbreviated Name Abbreviated Name Olanzapine embonate 210mg inj vials Start Date 26-07-2010

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Powder and solvent for suspension for injection
Ontology Form/Route
suspensioninjection.intramuscular-deep
Name Basis
INNM - International Non-proprietary Name (Modified)

Codes

ATC Code
N05AH03
BNF Codes
  • BNF code 04020200
SNOMED Codes
Code Start Date End Date
17037611000001102 07-04-2010

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Olanzapine embonate monohydrate Based on Base Substance Olanzapine 210 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial 14276 Part VIIIA Category C